{"id":"menopur-gonal-f","safety":{"commonSideEffects":[{"rate":"1-10%","effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":"5-15%","effect":"Headache"},{"rate":"5-10%","effect":"Injection site reactions"},{"rate":"10-20%","effect":"Abdominal pain/bloating"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-15%","effect":"Ovarian cysts"}]},"_chembl":{"chemblId":"CHEMBL1201692","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MENOPUR is a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from human menopausal urine, while GONAL-F is recombinant FSH. Both work by binding to FSH receptors on ovarian follicles to promote follicular growth and maturation, increasing estrogen production and preparing multiple oocytes for retrieval during in vitro fertilization or other fertility treatments.","oneSentence":"MENOPUR and GONAL-F are gonadotropins that stimulate the ovaries to produce multiple eggs for assisted reproductive procedures.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:19.177Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovulation induction and controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles"},{"name":"Treatment of infertility in women with anovulation or poor ovarian response"}]},"trialDetails":[{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07457684","phase":"","title":"Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2025-12-05","conditions":"IVF Outcomes, OVARIAN STIMULATION","enrollment":846},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT05103228","phase":"NA","title":"Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders","status":"COMPLETED","sponsor":"Peter Kovacs MD","startDate":"2021-12-02","conditions":"Infertility, Ovarian Dysfunction","enrollment":190},{"nctId":"NCT01921166","phase":"PHASE4","title":"Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-01","conditions":"Infertility","enrollment":23},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT02554279","phase":"PHASE4","title":"MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-08-31","conditions":"Infertility","enrollment":620},{"nctId":"NCT05864937","phase":"","title":"C677T Methylenetetrahydrofolate Reductase Mutation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2011-12-01","conditions":"Mutation","enrollment":363},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT01354886","phase":"PHASE1","title":"Single Dose FSH-GEX™ in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-04","conditions":"Female Infertility","enrollment":19},{"nctId":"NCT01477073","phase":"PHASE1","title":"Multiple Dose FSH-GEX(TM) in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-10","conditions":"Female Infertility","enrollment":57},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT02418533","phase":"NA","title":"Mono-menotropins Versus rFSH Protocol on Embryo Quality","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2015-03","conditions":"Infertility, Fertility","enrollment":109},{"nctId":"NCT04458454","phase":"","title":"\"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles\"","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2019-12-02","conditions":"Infertility, Reproductive Techniques, Assisted, Oocyte Maturation","enrollment":11},{"nctId":"NCT04385342","phase":"PHASE4","title":"FSH Followed by HMG vs FSH Plus HMG in IVF","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2020-06-30","conditions":"IVF","enrollment":530},{"nctId":"NCT02179255","phase":"PHASE1, PHASE2","title":"Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2014-08-01","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":30},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT01882166","phase":"NA","title":"Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2013-10","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT02625519","phase":"PHASE4","title":"Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":180},{"nctId":"NCT03098199","phase":"NA","title":"AMH and Dosing Regimens for Initial IVF Stimulation Protocols","status":"COMPLETED","sponsor":"Reproductive Specialists of New York","startDate":"2015-10-22","conditions":"Infertility","enrollment":78},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT01577199","phase":"PHASE4","title":"RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2012-04","conditions":"Infertility","enrollment":""},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT01798862","phase":"PHASE2, PHASE3","title":"Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2013-03","conditions":"Repeated Implantation Failures","enrollment":100},{"nctId":"NCT02673632","phase":"","title":"The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-02","conditions":"Infertility","enrollment":30},{"nctId":"NCT02254928","phase":"PHASE4","title":"Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders","status":"TERMINATED","sponsor":"Vida Recoletas Sevilla","startDate":"2014-09","conditions":"Infertility","enrollment":26},{"nctId":"NCT02412904","phase":"PHASE4","title":"Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-01","conditions":"Infertility","enrollment":188},{"nctId":"NCT01923194","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-10","conditions":"Anovulation","enrollment":215},{"nctId":"NCT02503605","phase":"PHASE4","title":"Biosimilar Versus Urinary Gonadotropins","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2015-10","conditions":"Infertility","enrollment":130},{"nctId":"NCT02213627","phase":"PHASE4","title":"Use of Corifolitropin Alfa in Oocyte Donors","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2014-10","conditions":"Female Reproductive Problem, Infertility","enrollment":300},{"nctId":"NCT01922193","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-10","conditions":"Infertility","enrollment":263},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT02322398","phase":"","title":"Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2010-03","conditions":"Infertility","enrollment":848},{"nctId":"NCT01604044","phase":"PHASE1","title":"Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2012-05","conditions":"Female Infertility","enrollment":579},{"nctId":"NCT00298025","phase":"PHASE4","title":"A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-09","conditions":"Infertile Women Undergoing Assisted Reproductive Technology (ART)","enrollment":185},{"nctId":"NCT01225835","phase":"PHASE4","title":"Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-10","conditions":"Infertility","enrollment":124},{"nctId":"NCT01185782","phase":"PHASE3","title":"SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-02","conditions":"Infertility, Ovulation Induction","enrollment":300},{"nctId":"NCT00884221","phase":"PHASE3","title":"MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-07","conditions":"Infertility","enrollment":749},{"nctId":"NCT00805935","phase":"PHASE4","title":"Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-01","conditions":"Polycystic Ovarian Syndrome, Infertility","enrollment":110},{"nctId":"NCT01487486","phase":"","title":"Proteomics & Glyco-Proteomic Analysis of Follicular Fluid","status":"UNKNOWN","sponsor":"University of Cincinnati","startDate":"2011-12","conditions":"Polycystic Ovary Syndrome, Normal Volunteers","enrollment":30},{"nctId":"NCT00802360","phase":"PHASE4","title":"MENOPUR® Versus FOLLISTIM®","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2008-12","conditions":"Infertility","enrollment":173},{"nctId":"NCT00257556","phase":"PHASE4","title":"A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2005-10","conditions":"Infertility","enrollment":80},{"nctId":"NCT00830492","phase":"PHASE4","title":"Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-01","conditions":"Ovarian Stimulation","enrollment":200},{"nctId":"NCT00823602","phase":"PHASE3","title":"Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH","status":"UNKNOWN","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-03","conditions":"Infertility","enrollment":2},{"nctId":"NCT00669786","phase":"PHASE3","title":"Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"","conditions":"Ovarian Stimulation","enrollment":""},{"nctId":"NCT00334425","phase":"PHASE4","title":"The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.","status":"UNKNOWN","sponsor":"Central Jutland Regional Hospital","startDate":"2006-04","conditions":"Infertility","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":156,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"MENOPUR; GONAL-F","genericName":"MENOPUR; GONAL-F","companyName":"Central Jutland Regional Hospital","companyId":"central-jutland-regional-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MENOPUR and GONAL-F are gonadotropins that stimulate the ovaries to produce multiple eggs for assisted reproductive procedures. Used for Infertility treatment via assisted reproductive technology (ART) / in vitro fertilization (IVF), Ovulation induction in anovulatory women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}